Adam Davidson

[email protected]

Ultrasound AI helps solve real-world clinical problems

Artificial intelligence (AI) algorithms for ultrasound are helping to solve real-world clinical problems for end users, according to a new report from market research firm Omdia. AI is already helping ultrasound practitioners cope with strained resources.

November 26, 2020

2020 11 24 23 52 9427 Ultrasound Scanner Computerized 400

Page 1 of 1

Slab reconstruction provides visualization of subtle architectural distortion similar to that of standard 1-mm slices in a false-positive screening exam. Images include breast exams from a 45-year-old woman who underwent screening mammography. Craniocaudal tomosynthesis images with (A) 1-mm slices and (B) 6-mm slab reconstructions show an area of architectural distortion in the subareolar region of the left breast (arrow). (C) Targeted ultrasound imaging shows a corresponding irregular hypoechoic mass (arrow), which was subsequently biopsied. Pathologic examination revealed a sclerosing papillary lesion.

AI approach could improve DBT efficiency

AI-based slab reconstruction may help improve screening DBT workflows while not compromising on image quality.

Heather Jacene, MD

SNMMI: Incoming president talks meeting highlights, previews next year

Snmmi Thumb

SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients

The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails

Podcast: Telltale signs your MRI safety standards are inadequate

RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.

SNMMI: Theranostic approach may treat PSMA-negative prostate cancer

AI approach could improve DBT efficiency

By Amerigo Allegretto

AI-based slab reconstruction may help improve screening DBT workflows while not compromising on image quality.

June 2, 2026

Slab reconstruction provides visualization of subtle architectural distortion similar to that of standard 1-mm slices in a false-positive screening exam. Images include breast exams from a 45-year-old woman who underwent screening mammography. Craniocaudal tomosynthesis images with (A) 1-mm slices and (B) 6-mm slab reconstructions show an area of architectural distortion in the subareolar region of the left breast (arrow). (C) Targeted ultrasound imaging shows a corresponding irregular hypoechoic mass (arrow), which was subsequently biopsied. Pathologic examination revealed a sclerosing papillary lesion.

SNMMI: Incoming president talks meeting highlights, previews next year

By Kate Madden Yee

AuntMinnie.com interviewed incoming SNMMI president Heather Jacene, MD.

June 2, 2026

Heather Jacene, MD

SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients

By Kate Madden Yee

Metabolic status should be considered in post-therapy evaluation of obese differentiated thyroid cancer patients, researchers noted.

June 2, 2026

Podcast: Telltale signs your MRI safety standards are inadequate

Check your MRI safety sense.

June 2, 2026

The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails

SNMMI: Theranostic approach may treat PSMA-negative prostate cancer

By Amerigo Allegretto

A theranostic approach could help improve PET imaging for neuroendocrine prostate cancer care.

June 2, 2026

RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.

ASCO: Use of GLP-1 drugs linked to lower breast cancer cases

By Erik L. Ridley

A large retrospective study found sharply lower incidence of breast cancer among women who had received GLP-1 drugs.

June 2, 2026

SNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinoma

Researchers aim for "more precise molecular map" for kidney cancer.

June 1, 2026

A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.

SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater

By Kate Madden Yee

An increase in the use of radionuclide therapy has added burden to wastewater management systems.

June 1, 2026

SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year

F-18 GP1 is derived from elarofiban and selectively binds to glycoprotein IIb/IIIa receptors on activated platelets.

June 1, 2026

(Left) F-18 GP1 PET/CT images from a 75-year-old woman show multiple blood clots in the deep veins of the left leg (from the thigh to the calf), as well as several clots in the right calf. Venous ultrasound confirms blood clots in left thigh, knee and calf veins. PET/CT also detects clots in both lungs, which are confirmed by contrast-enhanced CT image. (Right) 18F-GP1 PET/CT images from a 70-year-old woman show widespread blood clots throughout the body. In addition to clots in the deep veins of both legs and the arteries of both lungs (A), the scan also detected unexpected clots in several other areas, including blood vessels near the skull/head (B), spine (C), heart (D), and pelvis (E). Further evaluation revealed that the patient had antiphospholipid syndrome, an autoimmune condition that increases the risk of abnormal blood clot formation.

SNMMI: Novel radiotracer effectively images overactive adrenal glands

University of Michigan researchers report on first-in-human study of SOAT1-targeted nevanimibe C-11.

June 1, 2026

Static PET-CT image of patient with hypercortisolism taken at 60 minutes post-injection.

SNMMI: Mouaz Al-Mallah discusses cardiac PET

In this interview, Mouaz Al-Mallah, MD, discusses cardiac PET imaging, including new efforts to create more access for patients and the impact of new radiotracers.

June 1, 2026

Mouaz Al Mallah Thumb1

ASCO: Proton therapy, IMRT both work well for prostate cancer

By Erik L. Ridley

Both modalities yielded similar outcomes, according to preliminary results from a large, prospective trial.

June 1, 2026

Page 1 of 230